Popular Articles

Oklahoma State Department Of Health Announces Results Of Triathlon Illness Investigation
The Oklahoma State Department of Health (OSDH) announced today that an investigation of gastrointestinal illness reported in a recent Oklahoma City triathlon was related to exposure to water during swimming practice sessions or during the swim portion of the event.

Anaesthetists Receive New Guidance To Help Resolve Dilemmas Posed By Do Not Attempt Resuscitation Orders
The body that represents anaesthetists in the UK and the Republic of Ireland has issued new
News of the day
Mind Welcomes Radical Reform Of Social Care, UK
As the Government sets out proposals to reform social care, leading mental health charity Mind welcomes the move to simplify the process and create a fairer system for the many thousands of people with mental health problems who currently pay for social care services.
Medical Devices

Drug Companies Increasingly Use Medical Science Liaisons

The Wall Street Journal reports that drug companies are increasingly using medical science liaisons: "Pharmaceutical companies are barred by the Food and Drug Administration from promoting unapproved drug uses, called off-label use, but they are using employees called "medical science liaisons," who are often physicians and pharmacists, as a legal way to discuss those uses. Medical science liaisons, who are considered medical rather than sales staff, have greater freedom than salespeople as they visit doctors offices to discuss the science behind a medicine, including unapproved uses." It notes: "The FDA requires traditional sales reps to refer information requests to their employers" medical or scientific staff, MSLs are usually on those staffs." The Journal reports: "Though still small, the number of MSLs has increased steadily, totaling 1,970 in 2008, up 48% from 1,335 in 2003, according to data for 12 major pharmaceutical and biotech companies compiled by PharmaForce International, a market-research firm. Partial numbers for 2009 indicate a decline to 1,640, but Sean McCrae, an executive at PharmaForce, says that number is "an aberration," reflecting across-the-board cuts in the industry. And companies appear to still be hiring MSLs: The online job-search site Monster.com lists many MSL job postings. At the same time, drug makers have been cutting their conventional sales forces. By the end of 2008, the number of U.S. sales reps had dropped to 90,000 from a peak of about 106,000 in 2006, according to ZS Associates, a consulting firm." The Journal notes that "the drug companies themselves argue that their medical-science and sales forces have different functions." It also adds that: "MSLs generally make at least 50% more than primary-care sales reps, who are paid an average of $86,000, including bonus" (Wang, 6/26). This information was reprinted from kaiserhealthnews.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily Health Policy Report, search the archives and sign up for email delivery at kaiserhealthnews.org. © Henry J. Kaiser Family Foundation. All rights reserved.

Adam Bianchi commented:

There will always be a place for the traditional sales rep to quickly disseminate information to physicians. But more healthcare providers have shut the door to the \"suits.\" Those people are sometimes the most active and influential in a medical community - that\'s when the MSLs and other field-based science types can help get information out in a way that feels valuable to the physicians and is compliant with the letter and spirit of the law.

27.04.2010


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):